Report Detail

Request for Sample of this report

Pharma & Healthcare Global Albumin (as Excipient) Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4732616
    • |
  • 13 August, 2026
    • |
  • Global
    • |
  • 124 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Albumin (as Excipient) market size was valued at US$ 1731 million in 2025 and is forecast to a readjusted size of US$ 2650 million by 2032 with a CAGR of 6.3% during review period.
Albumin excipients refer to human serum albumin (HSA) or recombinant human serum albumin (rHSA) used as excipients in biopharmaceuticals. Their primary functions include stabilizing the structure and activity of protein drugs, enhancing drug solubility and bioavailability as carriers, and serving as nutritional components in vaccines and cell culture media. With the advancement of biologics and vaccine development, the application of albumin excipients in drug formulations is becoming increasingly widespread.In 2025, global Albumin (as Excipient) production reached approximately 440 mt, with an average global market price of around US$ 3822 per kg.
The albumin excipient market is experiencing unprecedented growth opportunities due to the global rise in chronic diseases, rapid expansion of the biopharmaceutical industry, and increasing demand for efficient drug delivery systems. Particularly in vaccine development and gene therapy, albumin excipients have become indispensable components due to their excellent biocompatibility and stability. Furthermore, advancements in recombinant albumin technologies have made the production process safer and more controllable, further driving market growth.
Despite the promising prospects, the albumin excipient market faces several challenges. Firstly, the source and quality control of raw materials are critical, especially the supply of human-derived albumin, which may affect production stability. Secondly, stringent regulatory requirements and quality standards make the research and development process complex and time-consuming. Additionally, increasing market competition from emerging enterprises and technologies may threaten the market share of existing companies.
Downstream demand is primarily concentrated in areas such as vaccines, cell culture media, protein drugs, and gene therapies. With the rise of personalized medicine and precision therapy, the demand for high-quality excipients continues to increase. Moreover, the growing aging population globally is driving the demand for chronic disease treatment drugs, thereby boosting the need for albumin excipients.
The main raw materials for albumin excipients include human serum albumin and recombinant bovine serum albumin. Human serum albumin is primarily sourced from plasma collection; however, its supply is limited by the number of blood donors and ethical issues related to plasma collection. On the other hand, recombinant bovine serum albumin production relies on bioreactor technology, which has higher production costs and technical requirements. Therefore, the stable supply and cost control of raw materials are key factors influencing the development of the albumin excipient market.
This report is a detailed and comprehensive analysis for global Albumin (as Excipient) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Albumin (as Excipient) market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2021-2032
Global Albumin (as Excipient) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2021-2032
Global Albumin (as Excipient) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2021-2032
Global Albumin (as Excipient) market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/Kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Albumin (as Excipient)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Albumin (as Excipient) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL, Grifols, Takeda, Octapharma, Hualan Bio, CBPO, Shanghai RAAS, Kedrion, LFB Group, Tiantan Bio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Albumin (as Excipient) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
20% Concentrations
25% Concentrations
Other
Market segment by Product Form
Liquid Albumin
Lyophilized Albumin
Market segment by Functional Role
Stabilizer
Carrier Protein
Surface-protecting Agent
Lyoprotectant
Osmotic Regulator
Other
Market segment by Application
Cell Culture Media
Medical Excipient
Major players covered
CSL
Grifols
Takeda
Octapharma
Hualan Bio
CBPO
Shanghai RAAS
Kedrion
LFB Group
Tiantan Bio
Pailin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Albumin (as Excipient) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Albumin (as Excipient), with price, sales quantity, revenue, and global market share of Albumin (as Excipient) from 2021 to 2026.
Chapter 3, the Albumin (as Excipient) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Albumin (as Excipient) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Albumin (as Excipient) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Albumin (as Excipient).
Chapter 14 and 15, to describe Albumin (as Excipient) sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Albumin (as Excipient) Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 20% Concentrations
    • 1.3.3 25% Concentrations
    • 1.3.4 Other
  • 1.4 Market Analysis by Product Form
    • 1.4.1 Overview: Global Albumin (as Excipient) Consumption Value by Product Form: 2021 Versus 2025 Versus 2032
    • 1.4.2 Liquid Albumin
    • 1.4.3 Lyophilized Albumin
  • 1.5 Market Analysis by Functional Role
    • 1.5.1 Overview: Global Albumin (as Excipient) Consumption Value by Functional Role: 2021 Versus 2025 Versus 2032
    • 1.5.2 Stabilizer
    • 1.5.3 Carrier Protein
    • 1.5.4 Surface-protecting Agent
    • 1.5.5 Lyoprotectant
    • 1.5.6 Osmotic Regulator
    • 1.5.7 Other
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global Albumin (as Excipient) Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Cell Culture Media
    • 1.6.3 Medical Excipient
  • 1.7 Global Albumin (as Excipient) Market Size & Forecast
    • 1.7.1 Global Albumin (as Excipient) Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global Albumin (as Excipient) Sales Quantity (2021-2032)
    • 1.7.3 Global Albumin (as Excipient) Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 CSL
    • 2.1.1 CSL Details
    • 2.1.2 CSL Major Business
    • 2.1.3 CSL Albumin (as Excipient) Product and Services
    • 2.1.4 CSL Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 CSL Recent Developments/Updates
  • 2.2 Grifols
    • 2.2.1 Grifols Details
    • 2.2.2 Grifols Major Business
    • 2.2.3 Grifols Albumin (as Excipient) Product and Services
    • 2.2.4 Grifols Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Grifols Recent Developments/Updates
  • 2.3 Takeda
    • 2.3.1 Takeda Details
    • 2.3.2 Takeda Major Business
    • 2.3.3 Takeda Albumin (as Excipient) Product and Services
    • 2.3.4 Takeda Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Takeda Recent Developments/Updates
  • 2.4 Octapharma
    • 2.4.1 Octapharma Details
    • 2.4.2 Octapharma Major Business
    • 2.4.3 Octapharma Albumin (as Excipient) Product and Services
    • 2.4.4 Octapharma Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Octapharma Recent Developments/Updates
  • 2.5 Hualan Bio
    • 2.5.1 Hualan Bio Details
    • 2.5.2 Hualan Bio Major Business
    • 2.5.3 Hualan Bio Albumin (as Excipient) Product and Services
    • 2.5.4 Hualan Bio Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Hualan Bio Recent Developments/Updates
  • 2.6 CBPO
    • 2.6.1 CBPO Details
    • 2.6.2 CBPO Major Business
    • 2.6.3 CBPO Albumin (as Excipient) Product and Services
    • 2.6.4 CBPO Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 CBPO Recent Developments/Updates
  • 2.7 Shanghai RAAS
    • 2.7.1 Shanghai RAAS Details
    • 2.7.2 Shanghai RAAS Major Business
    • 2.7.3 Shanghai RAAS Albumin (as Excipient) Product and Services
    • 2.7.4 Shanghai RAAS Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Shanghai RAAS Recent Developments/Updates
  • 2.8 Kedrion
    • 2.8.1 Kedrion Details
    • 2.8.2 Kedrion Major Business
    • 2.8.3 Kedrion Albumin (as Excipient) Product and Services
    • 2.8.4 Kedrion Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Kedrion Recent Developments/Updates
  • 2.9 LFB Group
    • 2.9.1 LFB Group Details
    • 2.9.2 LFB Group Major Business
    • 2.9.3 LFB Group Albumin (as Excipient) Product and Services
    • 2.9.4 LFB Group Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 LFB Group Recent Developments/Updates
  • 2.10 Tiantan Bio
    • 2.10.1 Tiantan Bio Details
    • 2.10.2 Tiantan Bio Major Business
    • 2.10.3 Tiantan Bio Albumin (as Excipient) Product and Services
    • 2.10.4 Tiantan Bio Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Tiantan Bio Recent Developments/Updates
  • 2.11 Pailin Bio
    • 2.11.1 Pailin Bio Details
    • 2.11.2 Pailin Bio Major Business
    • 2.11.3 Pailin Bio Albumin (as Excipient) Product and Services
    • 2.11.4 Pailin Bio Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Pailin Bio Recent Developments/Updates
  • 2.12 Boya Bio
    • 2.12.1 Boya Bio Details
    • 2.12.2 Boya Bio Major Business
    • 2.12.3 Boya Bio Albumin (as Excipient) Product and Services
    • 2.12.4 Boya Bio Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Boya Bio Recent Developments/Updates
  • 2.13 Yuanda Shuyang
    • 2.13.1 Yuanda Shuyang Details
    • 2.13.2 Yuanda Shuyang Major Business
    • 2.13.3 Yuanda Shuyang Albumin (as Excipient) Product and Services
    • 2.13.4 Yuanda Shuyang Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Yuanda Shuyang Recent Developments/Updates
  • 2.14 Weiguang Bio
    • 2.14.1 Weiguang Bio Details
    • 2.14.2 Weiguang Bio Major Business
    • 2.14.3 Weiguang Bio Albumin (as Excipient) Product and Services
    • 2.14.4 Weiguang Bio Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Weiguang Bio Recent Developments/Updates

3 Competitive Environment: Albumin (as Excipient) by Manufacturer

  • 3.1 Global Albumin (as Excipient) Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Albumin (as Excipient) Revenue by Manufacturer (2021-2026)
  • 3.3 Global Albumin (as Excipient) Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Albumin (as Excipient) by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Albumin (as Excipient) Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Albumin (as Excipient) Manufacturer Market Share in 2025
  • 3.5 Albumin (as Excipient) Market: Overall Company Footprint Analysis
    • 3.5.1 Albumin (as Excipient) Market: Region Footprint
    • 3.5.2 Albumin (as Excipient) Market: Company Product Type Footprint
    • 3.5.3 Albumin (as Excipient) Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Albumin (as Excipient) Market Size by Region
    • 4.1.1 Global Albumin (as Excipient) Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Albumin (as Excipient) Consumption Value by Region (2021-2032)
    • 4.1.3 Global Albumin (as Excipient) Average Price by Region (2021-2032)
  • 4.2 North America Albumin (as Excipient) Consumption Value (2021-2032)
  • 4.3 Europe Albumin (as Excipient) Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Albumin (as Excipient) Consumption Value (2021-2032)
  • 4.5 South America Albumin (as Excipient) Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Albumin (as Excipient) Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Albumin (as Excipient) Sales Quantity by Type (2021-2032)
  • 5.2 Global Albumin (as Excipient) Consumption Value by Type (2021-2032)
  • 5.3 Global Albumin (as Excipient) Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Albumin (as Excipient) Sales Quantity by Application (2021-2032)
  • 6.2 Global Albumin (as Excipient) Consumption Value by Application (2021-2032)
  • 6.3 Global Albumin (as Excipient) Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Albumin (as Excipient) Sales Quantity by Type (2021-2032)
  • 7.2 North America Albumin (as Excipient) Sales Quantity by Application (2021-2032)
  • 7.3 North America Albumin (as Excipient) Market Size by Country
    • 7.3.1 North America Albumin (as Excipient) Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Albumin (as Excipient) Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Albumin (as Excipient) Sales Quantity by Type (2021-2032)
  • 8.2 Europe Albumin (as Excipient) Sales Quantity by Application (2021-2032)
  • 8.3 Europe Albumin (as Excipient) Market Size by Country
    • 8.3.1 Europe Albumin (as Excipient) Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Albumin (as Excipient) Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Albumin (as Excipient) Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Albumin (as Excipient) Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Albumin (as Excipient) Market Size by Region
    • 9.3.1 Asia-Pacific Albumin (as Excipient) Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Albumin (as Excipient) Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Albumin (as Excipient) Sales Quantity by Type (2021-2032)
  • 10.2 South America Albumin (as Excipient) Sales Quantity by Application (2021-2032)
  • 10.3 South America Albumin (as Excipient) Market Size by Country
    • 10.3.1 South America Albumin (as Excipient) Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Albumin (as Excipient) Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Albumin (as Excipient) Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Albumin (as Excipient) Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Albumin (as Excipient) Market Size by Country
    • 11.3.1 Middle East & Africa Albumin (as Excipient) Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Albumin (as Excipient) Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Albumin (as Excipient) Market Drivers
  • 12.2 Albumin (as Excipient) Market Restraints
  • 12.3 Albumin (as Excipient) Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Albumin (as Excipient) and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Albumin (as Excipient)
  • 13.3 Albumin (as Excipient) Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Albumin (as Excipient) Typical Distributors
  • 14.3 Albumin (as Excipient) Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Albumin (as Excipient). Industry analysis & Market Report on Albumin (as Excipient) is a syndicated market report, published as Global Albumin (as Excipient) Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Albumin (as Excipient) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo